202 related articles for article (PubMed ID: 1019165)
1. The use of saralasin in the recognition of angiotensinogenic hypertension.
Streeten DH; Dalakos TG; Anderson GH
Prog Biochem Pharmacol; 1976; 12():214-26. PubMed ID: 1019165
[TBL] [Abstract][Full Text] [Related]
2. Use of an angiotensin II antagonist (saralasin) in the recognition of "angiotensinogenic" hypertension;
Streeten DH; Anderson GH; Freiberg JM; Dalakos TG
N Engl J Med; 1975 Mar; 292(13):657-62. PubMed ID: 235090
[TBL] [Abstract][Full Text] [Related]
3. [Clinical usefulness of saralasin in human hypertension (author's transl)].
Fouchard M; Bichara M; Grüfeld JP; Barbanel C; Meyer P; Funck-Brentano JL
Nouv Presse Med; 1978 Feb; 7(7):539-43. PubMed ID: 643579
[TBL] [Abstract][Full Text] [Related]
4. Abnormal adrenal responsiveness and angiotensin II dependency in high renin essential hypertension.
Dluhy RG; Bavli SZ; Leung FK; Solomon HS; Moore TJ; Hollenberg NK; Williams GH
J Clin Invest; 1979 Nov; 64(5):1270-6. PubMed ID: 500810
[TBL] [Abstract][Full Text] [Related]
5. Evidence for an angiotensinogenic mechanism of the hypertension of Cushing's syndrome.
Dalakos TG; Elias AN; Anderson GH; Streeten DH; Schroeder ET
J Clin Endocrinol Metab; 1978 Jan; 46(1):114-8. PubMed ID: 752014
[TBL] [Abstract][Full Text] [Related]
6. [Effect of saralasin on normal blood pressure and on reno-vascular hypertension (author's transl)].
Beckerhoff R; Vetter W; Furrer J; Nussberger J; Schmied U; Siegenthaler W
Dtsch Med Wochenschr; 1976 Mar; 101(11):398-401. PubMed ID: 1253700
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of angiotensinogenic hypertension: the complementary roles of renal scintigraphy and the saralasin infusion test.
McAfee JG; Thomas FD; Grossman Z; Streeten DH; Dailey E; Gagne G
J Nucl Med; 1977 Jul; 18(7):669-75. PubMed ID: 874145
[TBL] [Abstract][Full Text] [Related]
8. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.
Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
Prog Biochem Pharmacol; 1976; 12():230-41. PubMed ID: 1019166
[TBL] [Abstract][Full Text] [Related]
9. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
Bing RF; Russell GI; Swales JD; Thurston H
J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
[TBL] [Abstract][Full Text] [Related]
10. [Saralasin test, renal vein renin and unilateral kidney blood flow in renovascular hypertension].
Helber A; Hummerich W; Bönner G; Meurer KA; Moritz G
Verh Dtsch Ges Kreislaufforsch; 1977; 43():208-9. PubMed ID: 613575
[No Abstract] [Full Text] [Related]
11. [Saralasin and prediction of the surgical result in renovascular arterial hypertension].
Mimran A; Deschodt G; Fourcade J; Barjon P
Arch Mal Coeur Vaiss; 1979 Nov; 72 Spec no():16-21. PubMed ID: 119507
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms involved in two-kidney renal hypertension induced by constriction of one renal artery.
Freeman RH; Davis JO; Watkins BE; Lohmeier TE
Circ Res; 1977 May; 40(5 Suppl 1):I29-35. PubMed ID: 870229
[TBL] [Abstract][Full Text] [Related]
13. The effect of an angiotensin antagonist (saralasin) on arterial pressure and plasma aldosterone in hemodialysis-resistant hypertensive patients.
Mimran A; Shaldon S; Barjon P; Mion C
Clin Nephrol; 1978 Feb; 9(2):63-7. PubMed ID: 639368
[TBL] [Abstract][Full Text] [Related]
14. Saralasin bolus test. Rapid screening procedure for renin-mediated hypertension.
Marks LS; Maxwell MH; Kaufman JJ
Lancet; 1975 Oct; 2(7939):784-7. PubMed ID: 78152
[TBL] [Abstract][Full Text] [Related]
15. [Renovascular hypertension: prediction of surgical treatment by angiotensin II blockade and saralasin (author's transl)].
Mimran A; Deschodt G; Barjon P; Mary H; Thevenet A
Nouv Presse Med; 1978 Dec; 7(43):3889-93. PubMed ID: 733540
[TBL] [Abstract][Full Text] [Related]
16. [Significance of renin-angiotensin system inhibitors in the diagnosis of hypertension].
Stumpe KO; Kolloch RE; Overlack A
Med Welt; 1977 Oct; 28(41):1645-9. PubMed ID: 927124
[No Abstract] [Full Text] [Related]
17. Clinical evaluation of renovascular hypertension and therapeutic decisions.
Vaughan ED; Case DB; Pickering TG; Sosa RE; Sos TA; Laragh JH
Urol Clin North Am; 1984 Aug; 11(3):393-407. PubMed ID: 6205495
[TBL] [Abstract][Full Text] [Related]
18. [Effect of saralasin infusion on glomerular filtration rate and sodium excretion in hypertensive patients (author's transl)].
de Franca Borges H; da Silva Saragoça MA; Kater CE; Ribeiro AB; Ajzen H; Ramos OL
Rev Bras Pesqui Med Biol; 1979 Sep; 12(4-5):293-302. PubMed ID: 531273
[TBL] [Abstract][Full Text] [Related]
19. Effect of saralasin on plasma renin activity and arginine-vasopressin in hypertensive man.
Arlart IP; Rosenthal J; Wagner H; Franz HE
Proc Eur Dial Transplant Assoc; 1978; 15():412-7. PubMed ID: 740674
[TBL] [Abstract][Full Text] [Related]
20. [Effect of the angiotensin antagonist saralasin (1-sar-8-ala-angiotensin II) on the blood pressure in secondary hypertension].
Beckerhoff R; Vetter W; Furrer J; Tuma J; Zàruba K; Vetter H; Siegenthaler W
Schweiz Med Wochenschr; 1976 Dec; 106(49):1738-41. PubMed ID: 1013696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
